Foa_Content_of_CDC-RFA-DP-23-0017 _Revised.pdf

Centers for Disease Control and Prevention

NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH

PROMOTION

Provision of Training and Technical Assistance to Enhance Comprehensive Cancer Control

Outcomes

CDC-RFA-DP-23-0017

05/08/2023

Table of Contents A. Funding Opportunity Description

B. Award Information

C. Eligibility Information

D. Application and Submission Information

E. Review and Selection Process

F. Award Administration Information

G. Agency Contacts

H. Other Information

I. Glossary

Part I. Overview

Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Subscribe" button link to ensure they receive notifications of any changes to CDC-RFA-DP- 23-0017. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Provision of Training and Technical Assistance to Enhance Comprehensive Cancer Control Outcomes C. Announcement Type: New - Type 1:

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52- 2.pdf. Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr- 46/index.html (See section 45 CFR 46.102(d)).

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-DP-23-0017

E. Assistance Listings Number:

https://www.grants.gov/ https://www.grants.gov/ https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

93.427 F. Dates:

1. Due Date for Letter of Intent (LOI):

2. Due Date for Applications:

05/08/2023 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Due Date for Informational Conference Call:

Thursday, March 30, 2023, from 3:00-4:00 pm, Eastern

Microsoft Teams meeting

Join on your computer, mobile app or room device

Click here to join the meeting

Meeting ID: 210 801 538 637 Passcode: 8xAdLf

Download Teams | Join on the web

Or call in (audio only)

+1 404-498-3000,,242232070# United States, Atlanta

(888) 994-4478,,242232070# United States (Toll-free)

Phone Conference ID: 242 232 070#

Find a local number | Reset PIN

Learn More | Meeting options

For additional information see the NOFO landing page at https://www.cdc.gov/cancer/ncccp/dp23-0017.htm

G. Executive Summary:

1. Summary Paragraph This multi-component NOFO will fund up to 3 recipients with national reach that have cancer expertise and capacity to provide training and technical assistance (TTA) on multisectoral partnerships; policy, system, and environmental change approaches; health equity change; and social determinants of change approaches to National Comprehensive Cancer Control Program (NCCCP) recipients and cancer coalitions. The aim of Component A is to provide tools and skills so all NCCCP recipients can succeed at convening and supporting a cancer coalition to use policy, system, and environmental change approaches when implementing the jurisdictional cancer plan. TTA topics align with the priorities, strategies, activities, and guidance provided to NCCCP recipients funded under CDC-RFA-DP22-2202 - Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations. The aim of Component B is to provide https://www.grants.gov/ https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjVhNjY5ZmUtZDAzYi00M2QzLWI2ZTEtYTE1NGRmNDgyYzgx%40thread.v2/0?context=%7b%22Tid%22%3a%229ce70869-60db-44fd-abe8-d2767077fc8f%22%2c%22Oid%22%3a%22fda40fdb-5e0d-4a8d-91b2-728e6068fc40%22%7d https://www.microsoft.com/en-us/microsoft-teams/download-app https://www.microsoft.com/microsoft-teams/join-a-meeting tel:+14044983000,,242232070# tel:8889944478,,242232070# https://dialin.teams.microsoft.com/f157e5c8-9e01-4021-b245-b3aec6e9a1bc?id=242232070 https://dialin.teams.microsoft.com/usp/pstnconferencing https://aka.ms/JoinTeamsMeeting https://teams.microsoft.com/meetingOptions/?organizerId=fda40fdb-5e0d-4a8d-91b2-728e6068fc40&tenantId=9ce70869-60db-44fd-abe8-d2767077fc8f&threadId=19_meeting_YjVhNjY5ZmUtZDAzYi00M2QzLWI2ZTEtYTE1NGRmNDgyYzgx@thread.v2&messageId=0&language=en-US https://www.cdc.gov/cancer/ncccp/dp23-0017.htm https://www.grants.gov/web/grants/view-opportunity.html?oppId=334471

TTA to scale interventions previously piloted by the CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients.

a. Eligible Applicants:

Open Competition

b. Funding Instrument Type:

CA (Cooperative Agreement)

c. Approximate Number of Awards Up to 2 Component A awards and up to 1 Component B award.

d. Total Period of Performance Funding:

$10,500,000

e. Average One Year Award Amount:

$600,000 Average award for Component A is $750,000. Average award for Component B is $600,000.

f. Total Period of Performance Length:

5 year(s)

g. Estimated Award Date:

August 30, 2023

h. Cost Sharing and / or Matching Requirements:

No Cost sharing or matching funds are not required for this program. Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text

A. Funding Opportunity Description

1. Background

a. Overview Cancer remains the second leading cause of death in the United States for both men and women.

In 2019, more than 1.7 million people were diagnosed with cancer and 600,000 people died from this disease. Since 1990, CDC’s Division of Cancer Prevention and Control (DCPC) has been committed to advancing cancer prevention nationwide for everyone through a variety of activities at the national, state, territorial, and tribal levels. The Division's overall goal is to work toward having all people free of cancer while improving health equity through prevention, screening, and promoting health and wellness in cancer survivors.

This NOFO consists of two components:

1. Up to 2 Component A recipients will provide training and technical assistance on multisectoral partnerships; policy, system, and environmental change approaches; health equity change; and social determinants of change approaches to NCCCP recipients and CCC coalitions.

2. One Component B recipient will provide training and technical assistance to scale interventions previously piloted by the CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients.

Applicants may apply for either Component A or Component B, or they may apply for both components. If applying for both Component A and Component B, a separate application with a separate proposed work plan and budget must be submitted for each component. Receiving a Component B award is not contingent upon receiving a Component A award.

This NOFO funds the provision of training and technical assistance (TTA) to enhance organizational capacities, increase use of effective interventions, and facilitate achievement of program outcomes that contribute to cancer risk, morbidity, and mortality reductions. This will increase effectiveness of the work of NCCCP recipients and cancer coalitions.

CDC recently conducted four pilot implementation projects to decrease cancer burden and promote health equity with a small subset of NCCCP recipients. The projects are: 1) Using Project ECHO and Patient Navigation to Improve the Health and Wellness of Cancer Survivors in Rural Communities (with practice guide: Public Health Strategies to Help Cancer Survivors in Rural Communities) 2) Preventing Liver Cancer Among Opioid Users, 3) Increasing Receipt of Ovarian Cancer Care from a Gynecologic Oncologist, and 4) Addressing Risk Factors for Adult Cancers during Childhood. These four projects were designed to cross the continuum of cancer prevention, treatment, and survivorship, and yielded promising and best practices to implement specific evidence-based interventions that prevent and control cancer at the community level. As these projects are ready for wider dissemination to the broader NCCCP recipient population, CDC is promoting and encouraging these projects to be included in program planning in years 2 through 5 of DP22-2202. These 4 projects are the foundation for Component B.

b. Statutory Authorities This program is authorized under sections 301(a) and 317(k)(2) of the Public Health Service Act as amended [42 USC 241(a) and 42 USC 247b(k)(2)].

c. Healthy People 2030 This NOFO supports the following Healthy People 2030 topic areas:

Cancer Overweight and Obesity Vaccination Tobacco Use

d. Other National Public Health Priorities and Strategies This NOFO supports strategies to increase and improve the quality of cancer screening, community- clinical linkages, and preventive services in the following national plans and guidelines:

The Guide to Community Preventive Services Social Determinants of Health at CDC https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/survivors/health-care-providers/rural/index.htm https://www.cdc.gov/cancer/survivors/health-care-providers/rural/index.htm https://www.cdc.gov/cancer/liver/opioid-users/index.htm https://www.cdc.gov/cancer/ovarian/gynecologic-oncologist/index.htm https://www.cdc.gov/cancer/ovarian/gynecologic-oncologist/index.htm https://www.cdc.gov/cancer/ncccp/dp23-0017.htm https://www.cdc.gov/cancer/ncccp/dp23-0017.htm https://www.grants.gov/web/grants/view-opportunity.html?oppId=334471 https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer https://health.gov/healthypeople/objectives-and-data/browse-objectives/overweight-and-obesity https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination https://health.gov/healthypeople/objectives-and-data/browse-objectives/tobacco-use https://www.thecommunityguide.org/ https://www.cdc.gov/about/sdoh/index.html

U.S. Preventive Services Task Force

e. Relevant Work This NOFO supports NCCCP priorities, goals and objectives found in CDC-RFA-DP22-2202 - Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations and emphasizes coalition development and partner engagement.

This NOFO also builds upon previously funded technical assistance and training cooperative agreements funded by CDC-RFA-DP18-1805, Provision of Technical Assistance and Training to Assure Comprehensive Cancer Control Outcomes and CDC-RFA-DP13-1315, National Support to Enhance Implementation of Comprehensive Cancer Control Activities.

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

Strategies and Activities Short term Outcomes Intermediate Outcomes

Long-term Outcomes

Component A

A1: Develop training and technical assistance (TTA) plan using information gathered through variety of sources.

A2: Convene, support, and sustain partnerships and/or partnership networks necessary to support implementation of TTA activities.

A3: Use a variety of training delivery methods to deliver TTA, including the establishment of peer learning/communities of practice to facilitate information sharing across National Comprehensive Cancer Control Program (NCCCP) recipients.

A4: Monitor and evaluate TTA efforts and disseminate findings.

Component A

Increased networking, partnerships, and coordination among TTA providers

Identified training needs.

Provision of effective TTA to programs

Increased reach of TTA activities to NCCCP recipients and cancer coalitions

Increased knowledge, awareness, and attitudes regarding evidence-based interventions (EBIs) and resources that aid implementation

Increased adoption of strategies and evidence-based interventions to improve and sustain efforts of

NCCCP

recipients and cancer coalitions

Increased capacity, reach, utilization, impact, and sustainability of NCCCP recipients and cancer coalitions https://uspreventiveservicestaskforce.org/uspstf/ https://www.grants.gov/web/grants/view-opportunity.html?oppId=334471 https://www.grants.gov/web/grants/view-opportunity.html?oppId=334471 https://www.grants.gov/web/grants/search-grants.html?keywords=DP18-1805 https://www.grants.gov/web/grants/search-grants.html?keywords=DP18-1805 https://www.grants.gov/web/grants/search-grants.html?keywords=DP13-1315 https://www.grants.gov/web/grants/search-grants.html?keywords=DP13-1315

Component B

B1: Provide specific TTA to NCCCP recipients for implementation of 3 of 4 defined implementation projects.

B2: Assist NCCCP recipients with developing new and tailoring existing materials and methods to reflect their specific population experiencing disparities in cancer.

B3: Convene and support community of practice of NCCCP recipients to foster collaboration, further expertise, encourage information sharing, and promote sustained conduct of implementation projects.

B4: Assist NCCCP recipients to collect data, evaluate, and disseminate activities conducted and populations reached for each implementation project.

B5: Monitor and evaluate TTA efforts and disseminate findings.

Component B

Increased capacity of NCCCP recipients to implement projects previously piloted by CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients

i. Purpose The purpose of this NOFO is to support TTA to strengthen the capacity of NCCCP recipients and cancer coalitions to make progress toward the priorities listed in CDC-RFA-DP22-2202.

Component A provides TTA to NCCCP recipients to increase their ability to support and enhance knowledge, capacity, reach, impact, and sustainability of cancer coalitions. Component B provides TTA to scale interventions previously piloted by CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients.

ii. Outcomes Recipients are expected to achieve the following outcomes by the end of the period of performance:.

Component A:

Short-term outcomes

Increased reach of TTA activities to NCCCP recipients and cancer coalitions Increased knowledge, awareness, and attitudes regarding evidence-based interventions and resources that aid implementation.

Component B:

Short-term outcomes

Increased capacity of NCCCP recipients to implement projects previously piloted by CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients.

Components A and B:

Intermediate Outcome

Increased adoption of strategies and evidence-based intervention to improve and sustain NCCCP recipient / cancer coalition efforts.

iii. Strategies and Activities Component A - All strategies must be implemented by recipients of this component

1. Develop training and technical assistance (TTA) plan using information gathered through variety of sources. Collaboration is essential and recipients will:

a. Use sources such as existing information from TTA needs assessments, periodic assessments, input from other TTA provider(s), NCCCP program consultants, other CDC SMEs, and members of the broader public health community. Other TTA providers include the other recipients of this NOFO, and the CDC’s National Networks, which are funded to provide TTA to advance commercial tobacco use prevention and cancer prevention in populations experiencing tobacco- and cancer-related health disparities.

i. Topics included in the TTA plan must support strategies and activities required of NCCCP recipients funded under DP22-2202, and should describe the delivery methods that will be used (e.g., training for all recipients; technical assistance for small groups, which includes communities of practice and peer led training; as well as written resources).

ii. The TTA plan should specify training types, training materials that exist or need to be developed, timeline for delivering training, and staff who will deliver training.

Learning objectives for specific training should also be included.

iii. The TTA plan should be flexible to allow for changing needs of NCCCP recipients and CCC coalitions.

b. Conduct an environmental scan of existing resources to inform the TTA plan and reduce duplication. This includes scans of existing and emerging policy, system, and environmental (PSE) change approaches and social determinants of health (SDOH) strategies and policies that may facilitate or hinder PSE/SDOH improvements.

c. Conduct brief assessments with DP22-2202 recipients, CCC coalitions, and NCCCP program consultants to identify available cancer early detection/screening, prevention, survivorship, and coalition resources, as well as gaps that need to be filled.

i. Periodic assessments may be conducted annually or bi-annually. Timing of assessments should be coordinated with the other TTA providers funded under this NOFO and must align with DP22-2202 strategies and activities.

https://www.cdc.gov/tobacco/stateandcommunity/tobacco-control/coop-agreement/index.html

ii. Methods to gather input/assess needs might include, but are not limited to:

questionnaires, key informant interviews, polling, focus groups, as well as review of records and reports.

iii. Assessments should seek to determine DP22-2202 recipients’ preferences for TTA timing, agenda and training objectives, and TTA method.

2. Convene, support, and sustain partnerships and/or partnership networks necessary to support implementation of TTA activities

a. Engage other TTA providers, NCCCP program consultants, other CDC SMEs, and members of the broader public health community to implement TTA plan.

b. Partner with various SMEs, with a variety of perspectives and experiences, across the country to deliver meaningful TTA.

c. Work with CDC SMEs to help ensure consistent messaging and appropriate alignment with evolving needs of NCCCP recipients.

d. Work collaboratively with recipients of this NOFO to establish one advisory group with representatives from the groups listed above. The advisory group will be used by all TTA providers to ensure TTA activities are relevant.

3. Use a variety of training delivery methods to deliver TTA, including the establishment of peer learning/communities of practice to facilitate information sharing across NCCCP recipients. At a minimum, recipients will:

a. Implement TTA methods that follow CDC’s Quality Training Standards. TTA may be in person and/or virtual.

b. Co-brand with CDC resources developed under this NOFO, at CDC’s discretion. This will help increase exposure to resources and make resources available not only on recipients’ website but also on CDC website. Co-branded resources will need to go through CDC clearance process.

c. Communicate resources to all NCCCP recipients, cancer coalitions, and the larger cancer prevention and control community. This includes posting resources to CDC’s DCPC sites.

d. Implement peer learning/communities of practice to provide a forum for NCCCP recipients and CCC coalitions to learn from one another’s experiences.

f. Facilitate community of practice sessions that include both a brief didactic component and an opportunity for peer-to-peer learning. Frequency and agenda should be identified with input from NCCCP recipients and CCC coalitions.

4. Monitor and evaluate TTA efforts and disseminate findings

a. Create a performance measurement plan to report short-, intermediate-, and long- term outcomes.

b. Develop and implement annual evaluation plans.

https://www.cdc.gov/training/development/standards/index.html

c. Use program evaluation results for continuous program improvement by sharing results with program staff and partners to inform program work plan revision and subsequent annual evaluation plans.

d. Develop dissemination documents including an evaluation report, to share lessons learned.

Component B - All strategies must be implemented by recipients of this component

The foundation for component B are these 4 CDC pilot projects: 1) Using Project ECHO and Patient Navigation to Improve the Health and Wellness of Cancer Survivors in Rural Communities (with practice guide: Public Health Strategies to Help Cancer Survivors in Rural Communities) 2) Preventing Liver Cancer Among Opioid Users, 3) Increasing Receipt of Ovarian Cancer Care from a Gynecologic Oncologist, and 4) Addressing Risk Factors for Adult Cancers during Childhood. Component B will require specific individualized and group (i.e., Community of Practice) technical assistance, particularly in building partnerships, data collection, evaluation, and dissemination at the community level. The pilot project materials and methods from the subset of NCCCP recipients are publicly available (websites specified above) and serve as valuable models for implementation in the larger NCCCP setting. The Component B recipient will assist a subset of NCCCP recipients in adapting materials and methods to scale up 3 out of 4 of these interventions and must include Using Project ECHO and Patient Navigation to Improve the Health and Wellness of Cancer Survivors in Rural Communities as one of the 3 projects.

1. Provide specific TTA to NCCCP recipients for implementation of 3 of 4 defined implementation projects (1) Survivors, 2) Liver Cancer, 3) Ovarian Cancer, and 4) Prevention to increase health equity.

a. Recipients must assist with project, Using Project ECHO and Patient Navigation to Improve the Health and Wellness of Cancer Survivors in Rural Communities, and can choose two additional projects they have expertise and experience in for this award. Recipients must work with a broad number of NCCCP recipients in the implementation of these projects. CDC will assist with identifying NCCCP recipients in need of TTA.

b. Assist NCCCP recipients with identifying local partners within their community to help with implementation (e.g., pediatricians, liver and ovarian cancer practitioners, hospital systems and networks, patient navigator and community health work organizations).

c. Gather existing resources from pilot implementation projects. Recipients should gather relevant information for implementation from other resources such as NCI’s Evidence- Based Cancer Control Practice Program; CDC’s QuickStart Guide, which provides extensive list of cancer-related evidence-based interventions, relevant publications, and other information for cancer control planning; and CDC’s Health Equity Guide for Cancer Prevention and Control Programs. (NOTE from NOFO author: CDC’s Quick Start Guide and CDC’s Health Equity Guide for Cancer Prevention and Control Programs are in the process of being updated and will be made available on Web soon)

d. Implement TTA methods that follow CDC’s Quality Training Standards.

https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/survivors/health-care-providers/rural/index.htm https://www.cdc.gov/cancer/survivors/health-care-providers/rural/index.htm https://www.cdc.gov/cancer/liver/opioid-users/index.htm https://www.cdc.gov/cancer/ovarian/gynecologic-oncologist/index.htm https://www.cdc.gov/cancer/ovarian/gynecologic-oncologist/index.htm https://www.cdc.gov/cancer/ncccp/dp23-0017.htm https://www.cdc.gov/cancer/ncccp/dp23-0017.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://www.cdc.gov/cancer/ncccp/success-stories/echo-navigation.htm https://ebccp.cancercontrol.cancer.gov/index.do https://ebccp.cancercontrol.cancer.gov/index.do https://www.cdc.gov/cancer/ncccp/related-programs/technical-assistance-training.htm https://www.cdc.gov/cancer/ncccp/related-programs/technical-assistance-training.htm https://www.cdc.gov/training/development/standards/index.html

2. Assist NCCCP recipients with developing new and tailoring existing materials and methods to reflect their specific population experiencing disparities in cancer.

For example, appropriately alter materials to the specific racial, ethnic, geographic, or age-specific population and support methods for implementation that suit the population.

3. Convene and support community of practice of NCCCP recipients to foster collaboration, further expertise, encourage information sharing, and promote sustained conduct of implementation projects.

a. Recipients can include CDC program consultants and other SMEs. Each project should have a separate Implementation Community of Practice consisting of NCCCP recipients who are working on that project.

b. The recipient is expected to meet during all phases of implementation (e.g., planning, data collection, evaluation, dissemination). The schedule of meetings for the Implementation Community of Practice can be determined by the recipient and NCCCP recipients.

4. Assist NCCCP recipients to collect data, evaluate, and disseminate activities conducted and identify populations reached for each project. Recipient works with the subset of NCCCP recipients to evaluate the project implementation.

a. Help NCCCP recipients identify priority populations (i.e., populations that are disproportionally affected by cancer) that would benefit most from project implementation (e.g., race-, ethnic-, geographic-, age-specific data analyses of cancer incidence, mortality or survival; hospital use or care-seeking behavior analyses; cancer risk factor analyses).

b. Work with NCCCP recipients to develop appropriate data collection methods and instruments (e.g., surveys/pre-post-tests) to assess reach and success of implementation activities. Data collection instruments and methods should be designed with the population in mind.

c. Assist NCCCP recipients in evaluating the success of implementation and identify areas for improvement. Potential additional populations within the NCCCP recipient area that may benefit from this implementation project should also be identified.

d. Help develop plans for ongoing sustainability of activities. Data collection during implementation can also be used for evaluation purposes.

e. Work with NCCCP recipients to disseminate methods, results, successes, and lessons learned from the implementation project. A variety of dissemination products should be considered including slide sets, one-page project descriptions, one-page success stories, podcasts, and scientific publications. Dissemination products should be posted on the web.

5. Monitor and evaluate TTA efforts and disseminate findings. Recipient is expected to evaluate their efforts to implement the cooperative agreement.

a. Develop and implement annual evaluation plans.

b. Develop dissemination documents to share lessons learned. For example, dissemination products may include local landscape and surveillance analyses, summaries of partners convened and work done, mini-reports of the numbers of people reached, and survey responses.

1. Collaborations

a. With other CDC projects and CDC-funded organizations:

Component A recipients are required to collaborate extensively with CDC programs, CDC-funded organizations and NCCCP recipients. At a minimum, applicants should describe how they will collaborate with the following: CDC program consultants from the National Comprehensive Cancer Control Program, CDC subject matter experts, CDC’s Comprehensive Cancer Control Branch staff, training and technical assistance recipients under DP23-0017, and CDC’s National Networks. Applicants are required to explain how each collaboration will assist recipient in implementing activities and achieving the NOFO period of performance outcomes. As appropriate and relevant, collaborations may also include other CDC-funded chronic disease and risk-factor related programs and the Cancer Prevention and Control Research Network. Such collaborations will support the achievement of NOFO outcomes by eliminating duplication of training and technical assistance efforts.

Component B recipient will collaborate extensively with CDC SMEs who led the 4 pilot projects as well as NCCCP recipients.

b. With organizations not funded by CDC:

Component A recipients are expected to work with non-CDC funded networks and organizations to leverage subject matter expertise and other resources related to the desired outcomes, strategies, and activities of this NOFO. This may include, but is not limited to networks and organizations such as the Comprehensive Cancer Control National Partnership (CCCNP) member organizations, American Cancer Society Roundtables, chronic disease partner networks, organizations that represent disparate populations at high risk for cancer, professional associations, and academic institutions.

Applicants are required to provide at least 3 letters of support (LOS) or Memoranda of Understanding/Agreement (MOU/MOA) to document collaborations with non-CDC-funded organizations. The LOS or MOU/MOA should describe the organization's commitment to assisting in TTA efforts that could include but are not limited to planning support, provision of resources (e.g., subject matter experts, facilities, funding), promotion of TTA efforts, and implementation of TTA activities.The letter of support should be dated within 60 days of the application due date. Applicants must file the LOS, MOU, or MOA, as appropriate, name the file "LOS, MOU or MOA” and upload it as a PDF file at www.grants.gov

Component B: N/A

2. Target Populations This NOFO aims to increase capacity among the recipients of DP22-2202 to identify the populations that are disproportionally affected by cancer and implement culturally appropriate https://www.cdc.gov/tobacco/stateandcommunity/tobacco-control/coop-agreement/index.html http://cpcrn.org/ http://cpcrn.org/ http://cccnationalpartners.org/ http://cccnationalpartners.org/ https://www.cancer.org/about-us/our-partners/american-cancer-society-roundtables.html http://www.grants.gov interventions and support policy, systems, and environmental strategies to increase their access and benefits from cancer prevention, screening, referral, and survivorship services.

a. Health Disparities Applicants are required to describe how they will provide TTA that supports NCCCP recipients and cancer coalitions in their efforts to make progress towards the priorities listed in DP22- 2202. One of those priorities is to reduce disparities in cancer outcomes among racial and ethnic groups, low-SES groups, rural or other geographically isolated communities, other population-based or geographically determined communities, and large numbers of persons at disproportionate risk for and affected by cancer. NCCCP recipients review surveillance data to identify cancer disparities by race, ethnicity, gender identity, sexual orientation, geography, socioeconomic status, disability status, primary language, and health literacy. Applicants are also required to address the inclusion of intersectional population(s) within the identified population of focus that can benefit from the program strategies listed in this NOFO. These identified intersectional population(s) can include persons with disabilities, individuals who were formally incarcerated, individuals experiencing housing insecurity or who are unsheltered, older adults, immigrants, military/veteran population, women, or any overlapping and intersecting groups or populations who may otherwise be overlooked by CDC and other public health funded programs. And finally, all 5 areas identified by CDC's NCCDPHP’s Approach to Social Determinants of Health impact cancer prevention and control and should be considered to promote health and wellness for all.

iv. Funding Strategy This NOFO consists of two components:

1. Up to 2 Component A recipients will receive up to $750,000 to provide training and technical assistance on multisectoral partnerships; policy, system, and environmental change approaches; and address social determinants to improve health and advance health equity to NCCCP recipients and CCC coalitions

2. One Component B recipient will receive up to $600,000 to provide training and technical assistance to scale interventions previously piloted by the CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients.

Applicants may apply for either Component A or Component B, or they may apply for both components. If applying for both Component A and Component B, a separate application with a separate proposed work plan and budget must be submitted for each component. Receiving a Component B award is not contingent upon receiving a Component A award.

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

The table below aligns with the logic model and shows the connection between the overarching focus areas, specific strategies, outcomes, and performance measures.

Strategy Short Term Performance Measures

Intermediate Performance Measures

Long-Term Performance Measures https://www.grants.gov/web/grants/view-opportunity.html?oppId=334471 https://www.grants.gov/web/grants/view-opportunity.html?oppId=334471 https://www.cdc.gov/chronicdisease/healthequity/sdoh-and-chronic-disease/nccdphps-approach-to-social-determinants-of-health.html https://www.cdc.gov/chronicdisease/healthequity/sdoh-and-chronic-disease/nccdphps-approach-to-social-determinants-of-health.html

Component A

Use a variety of training delivery methods to deliver TTA, including the establishment of peer learning/communities of practice to facilitate information sharing across NCCCP recipients.

#, mode, and type of training and technical assistance provided for

DP22-2202

recipients (Process)

# of DP22-2202 recipient staff/coalition members participating in training per recipient (Process)

Component B

Provide specific TTA to NCCCP recipients for implementation of 3 of 4 defined implementation projects.

# and type of implementation activities conducted as a result of TTA provided

# and type of strategies and evidence based interventions adopted as a result of TTA efforts

CDC will conduct a formal evaluation with recipients to determine if the NOFO strategies and activities have been implemented as expected and if the intended period of performance outcomes have been achieved. CDC will follow the CDC Framework for Program Evaluation to design a comprehensive evaluation to include process measures for the strategies and activities in the logic model and outcome measures for the period of performance in the logic model.

Performance measures and evaluation findings will identify whether the provision of training and technical assistance contributed to the promotion and expansion of implementation of evidence-based interventions addressing primary prevention, screening, survivorship, and disparities which, in turn, can lead to reductions in cancer risk, morbidity, and mortality. Performance measures and evaluation findings will also be used to assess recipient compliance with requirements of this NOFO, making budgetary decisions, and informing guidance and technical assistance.

CDC will disseminate findings from the evaluation through dissemination products that articulate evaluation findings and recommendations through products such as manuscripts, program publications, and presentations.

CDC will only collect data that is consistent with key evaluation questions and the identified process and outcome performance measures to ensure that data collection is limited only to data https://www.cdc.gov/evaluation/framework/index.htm that will be analyzed and used for program improvement, monitoring, and documented outcomes.

CDC will use information collected through programmatic reviews (e.g. program plans, evaluation plans and reports, action plans), key informant interviews, focus groups of program implementers and key stakeholders, and electronic surveys to answer key CDC evaluation questions, such as:

Component A

1. To what extent have the funded TTA providers increased networking, partnerships, and coordination among TTA providers?

2. To what extent did the training and technical assistance activities implemented by the funded TTA providers reach NCCCP recipients and cancer coalitions?

3. What is the impact of the training and technical assistance provided by the funded TTA providers on state, tribal, territorial, community and local jurisdictions’ ability reach populations of focus using evidence-based/promising practice PSE change interventions, innovative interventions addressing upstream SDOH?

Component B

1. What is the impact of the training and technical assistance provided by the funded TTA providers on the capacity of NCCCP recipients to implement projects previously piloted by CDC Comprehensive Cancer Control Branch within a subset of NCCCP recipients?

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How the applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP) as new pertinent information becomes available. If applicable, throughout the lifecycle of the project. Updates to DMP should be provided in annual progress reports. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data;

data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additional-requirements/ar-25.html.

https://www.cdc.gov/grants/additional-requirements/ar-25.html

Where the applicant chooses to, or is expected to, take on specific evaluation studies, the applicant should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

Component A and B: Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How the applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan within the first 6 months of award, as described in the Reporting Section of this NOFO.

Since this NOFO does not involve the generation or collection of public health data, a Data Management Plan is not required.

Component A and B recipients will submit an annual evaluation plan to CDC that describes the recipient’s intentions to evaluate the workplan and the program interventions. After the first year, the TTA recipient will also submit an annual report that summarizes the findings of the evaluation conducted.

The following 6 steps follow CDC’s Framework for Program Evaluation. Applicants must submit a draft evaluation plan to CDC that includes:

1. A description of partners and primary uses who will be engaged throughout the evaluation. The plan must also describe a concerted effort to ensure that the primary intended users perspective and insight were taken into account when developing the evaluation plan.

2. A description of the program. A logic model serves as the visual depiction of the program, clearly outlining program resources, activities, outputs and outcomes. The logic model should not be a duplication of the model published in the NOFO, rather it should describe how the applicant will operationalize the NOFO requirements given its unique context, capacity and understanding of the program.

3. Evaluation questions that address the implementation of the strategies and activities of the NOFO.

4. Develop an evaluation planning matrix that includes information regarding how the evaluation questions will be addressed though: indicators, data collection methods and data sources.

5. A description of how data will be analyzed using traditional qualitative, quantitative or mixed methods.

6. A description of how evaluation results will be shared and how the results will be used to inform program planning and evaluation for the next year, for example, how annual evaluation reports will be published on a publicly available website.

This plan will be reviewed by CDC subject-matter experts who will submit to recipients an evaluation plan feedback report with recommendations. Recipients must revise the evaluation plan within 30 days upon receipt of the feedback report.

c. Organizational Capacity of Recipients to Implement the Approach Component A and B applicants must meet the following criteria to fully demonstrate capacity to carry out the strategies outlined in the NOFO (some exceptions for Component B are noted):

Applicants must describe:

Background

National presence, perspective and organizational focus dedicated to advancing the NCCCP, specifically an existence of local affiliates or chapters with demonstrated success or experience supporting cancer control activities to ensure national reach/impact. Applicants should submit CV's and organizational chart(s) to demonstrate existence of local affiliates or chapter. Applicants must name this file "CVs/Resumes" or "Organizational Charts" and upload it at www.grants.gov. Component B does not need to meet this requirement.

Experience working with NCCCP recipients and cancer coalitions; experience includes establishing appropriate relationships, collaborating to develop and implement public health program activities, and evaluating related to outcomes. Component B does not need to meet this requirement.

Experience working with other TTA providers to create a comprehensive TTA plan, use all TTA providers’ different resources, and reduce duplication of effort. Component B does not need to meet this requirement.

Experience providing TTA in 1) developing jurisdictional plans,

2) strengthening coalitions, and 3) implementing policy, systems, and environmental change approaches that improve health outcomes.

Experience using adult learning strategies to provide training and technical assistance opportunities to public health programs, coalitions, and partners.

Capacity to engage or convene diverse, multi-sector public health partners or organizations to impact cancer control.

Experience working with communities to adapt and scale interventions and promising practices in priority communities.

Experience working to reduce health equities.

Content-specific Capacity https://www.grants.gov/

Subject-matter expertise and experience in areas such as policy, systems, and environmental change for cancer control.

Ability to follow CDC’s Quality Training Standards.

Capacity to communicate to a variety of audiences including, but not limited to, public health practitioners, decision-makers, scientists and physicians, and other CDC funded recipients.

Ability to facilitate a seamless interface between the provision of TTA provided by CDC (via program consultants) and the TTA provided by Comprehensive Cancer Control National Partnership. Component B does not need to meet this requirement.

Program management

Qualified and experienced staff identified and retained to ensure program success. Applicants should submit an Organizational Chart and Curriculum Vitas showing the key staff and their assigned duties. Applicants must name this file "CVs/Resumes" or "Organizational Charts" and upload it at www.grants.gov.

Ability to conduct ongoing performance management, performance monitoring and evaluation.

Experience in fiscal management, monitoring and reporting, including development and implementation of a resource allocation plan.

Experience using technological tools or resources to execute proposed strategies (i.e., methods of communicating with CCC program managers and cancer coalition leaders via, at minimum, a website and email distribution list).

Experience in administrative management of the required procurement efforts including the ability to write and award contracts.

d. Work Plan Work Plan Template Component A and B applicants: The CDC recommends the following work plan format.

Applicants are not required to use this format. If this format is not used the elements of this format must be included. Recipients will be asked to complete future work plans and progress reports in CDC’s Award Management Platform (AMP). AMP is a web-based application used by grantor to document, track, and collaborate on critical award management tasks. Use of the template will aid with future data entry. Additional reporting elements may be added in the future.

DP23-0017 Work Plan Template (insert year)

NOFO Strategy:

Key Deliverables Proposed:

Activities Performance

Measure(s)

Start and End Date

Personnel Assigned https://www.cdc.gov/training/development/standards/index.html https://cccnationalpartners.org https://cccnationalpartners.org

1.

2.

3.

4.

5.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

f. CDC Program Support to Recipients

In the cooperative agreement, CDC staff is substantially involved in the program activities, above and beyond routine grant management. To assist recipients in achieving the purpose of this award, CDC will conduct the following activities:

Collaborate with recipients in TTA plan development, evaluation, performance measurement, program planning and capacity building, including connecting Component B recipients with appropriate NCCCP recipients.

Provide subject-matter experts that include NCCCP program consultants to collaborate with recipients in development of TTA efforts.

Collaborate with recipients in the development of publications, manuals, modules, etc.

that relate to the purpose of this NOFO, pending CDC approval. This includes co-branding with CDC.

Facilitate the exchange of information and coordination and collaboration between recipients funded under this announcement and CDC-RFA-DP23-0015 (i.e., National Networks).

Provide recipients periodic updates regarding comprehensive cancer control, including information on best practices related to NCCCP priorities of emphasis of primary prevention activities, coordination of secondary prevention activities; activities that address cancer survivor needs, elimination of health disparities, use of policy, systems and environmental approaches, and evaluation for outcome measurement.

Assist in dissemination of information, including success stories and evaluation results, about recipient programs to partner and public health audiences.

B. Award Information

1. Funding Instrument Type:

CA (Cooperative Agreement) CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism:

U58

3. Fiscal Year:

4. Approximate Total Fiscal Year Funding:

$2,100,000

5. Total Period of Performance Funding:

$10,500,000 This amount is subject to the availability of funds.

Estimated Total Funding:

$10,500,000

6. Total Period of Performance Length:

5 year(s) year(s)

7. Expected Number of Awards:

Up to 2 Component A awards and up to 1 Component B award.

8. Approximate Average Award:

https://www.grants.gov/web/grants/view-opportunity.html?oppId=3…